EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $237,008 | -23.0% | 4,789 | -20.7% | 0.00% | – |
| Q4 2021 | $308,000 | -10.2% | 6,041 | -1.8% | 0.00% | – |
| Q3 2021 | $343,000 | +10.6% | 6,150 | -15.0% | 0.00% | – |
| Q2 2021 | $310,000 | +16.5% | 7,235 | +13.6% | 0.00% | – |
| Q1 2021 | $266,000 | -13.6% | 6,369 | -3.8% | 0.00% | – |
| Q4 2020 | $308,000 | +8.8% | 6,619 | -0.5% | 0.00% | – |
| Q3 2020 | $283,000 | -11.3% | 6,653 | 0.0% | 0.00% | – |
| Q2 2020 | $319,000 | +16.4% | 6,653 | +11.8% | 0.00% | – |
| Q1 2020 | $274,000 | -18.2% | 5,949 | +6.7% | 0.00% | – |
| Q4 2019 | $335,000 | +2.8% | 5,575 | -3.5% | 0.00% | – |
| Q3 2019 | $326,000 | -4.1% | 5,779 | -5.3% | 0.00% | – |
| Q2 2019 | $340,000 | +65.0% | 6,102 | +49.4% | 0.00% | – |
| Q1 2019 | $206,000 | -58.1% | 4,085 | -42.5% | 0.00% | -100.0% |
| Q3 2018 | $492,000 | -18.1% | 7,102 | -10.5% | 0.00% | 0.0% |
| Q2 2018 | $601,000 | +81.0% | 7,937 | +26.3% | 0.00% | – |
| Q1 2018 | $332,000 | -3.8% | 6,283 | -2.8% | 0.00% | – |
| Q4 2017 | $345,000 | -11.5% | 6,464 | -1.1% | 0.00% | – |
| Q3 2017 | $390,000 | -24.6% | 6,539 | -0.2% | 0.00% | -100.0% |
| Q2 2017 | $517,000 | -11.9% | 6,553 | -7.4% | 0.00% | 0.0% |
| Q1 2017 | $587,000 | +18.8% | 7,077 | +13.6% | 0.00% | 0.0% |
| Q4 2016 | $494,000 | +10.0% | 6,229 | -2.9% | 0.00% | 0.0% |
| Q3 2016 | $449,000 | +77.5% | 6,414 | -1.7% | 0.00% | – |
| Q2 2016 | $253,000 | +11.0% | 6,524 | +11.5% | 0.00% | – |
| Q1 2016 | $228,000 | -56.0% | 5,849 | +0.1% | 0.00% | – |
| Q4 2015 | $518,000 | +20.7% | 5,846 | +1.0% | 0.00% | – |
| Q3 2015 | $429,000 | -6.7% | 5,789 | +1.9% | 0.00% | -100.0% |
| Q2 2015 | $460,000 | – | 5,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |